Article

Rheumatology Network to Join HCPLive Network in 2023

Beginning January 1, 2023, all new content and insights from the editorial teams of Rheumatology Network, Practical Cardiology and Endocrinology Network will be hosted on HCPLive.Com.

HCPLive Network logo over a white background

For years, Rheumatology Network® has served a key role in delivering topline news and expert-guided resources to every clinical stakeholder in the field of rheumatology. We’ve grown our audience, our offerings, and our very network of collaborative experts through an emphasis on the newest, most impactful and most-discussed subjects defining the field today—and potentially tomorrow.

We finish 2022 having accomplished many feats: a new record for site traffic, a bevy of new expert contributors and multimedia series, and a pronounced return to live, in-person meeting coverage and studio programs.

And best of all, we end the year with an exciting new partnership that allows us to expand our presence in rheumatology news.

Rheumatology Network®, along with sister sites Practical Cardiology ® and Endocrinology Network ®, will be officially merging with medical news site HCPLive®, becoming the longtime site’s representative rheumatology news source. Everything Rheumatology Network® has to offer—including its content, multimedia series, and teams of expert advisors—will be available on HCPLive.com, among a growing network of specialty-focused site coverage.

Rheumatology, in each component of academic, research and clinical status, has become representative of great changes to modern health care. Our care teams are more diverse in specialty and capability; our drug classes are becoming multifactorial; our strategies are becoming more collaborative and comprehensive. We hope to reflect these changes in our own partnership with HCPLive®, as our coverage will coexist—and, when relevant, overlap—with coverage from every other specialty.

Our site’s coverage, series and experts will begin to migrate to the HCPLive® rheumatology section in the coming weeks, along with Practical Cardiology® and Endocrinology Network® in their respective specialty sections. We’re excited to be joining a growing team that shares our valuation of specialty medical news and insights from key opinion leaders, and our prioritization on FDA and pipeline news, multimedia expert interviews and in-depth meeting coverage.

2022 was a hallmark year for Rheumatology Network®. We’re excited to see how much more what we started can grow with HCPLive® in 2023.

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
© 2024 MJH Life Sciences

All rights reserved.